Record International Cannabis Revenue
Tilray achieved a record revenue of $22.4 million in the international cannabis business in Q4, up 71% year-over-year.
Improved Gross Margins
Total cannabis gross margin increased by 400 basis points to 44% in Q4, and by 700 basis points for the fiscal year.
Strong Adjusted EBITDA Performance
Achieved the second-highest ever quarterly consolidated adjusted EBITDA of almost $28 million in Q4.
Debt Reduction and Financial Stability
Reduced debt by approximately $100 million and improved net debt-to-EBITDA ratio to 0.3x from 1.7x last year.
Expansion and Growth in Key Markets
European cannabis revenue increased organically by 112% in Q4, excluding Australia, and Germany achieved a revenue growth of 134% over the prior year quarter.